Literature DB >> 18552514

Ghrelin and eating disturbances in psychiatric disorders.

A Schanze1, U Reulbach, M Scheuchenzuber, M Groschl, J Kornhuber, T Kraus.   

Abstract

INTRODUCTION: Appetite and eating behavior are frequently altered in psychiatric patients. The newly discovered gut-derived neuropeptide ghrelin simulates hunger and weight gain. Therefore, it might be involved in appetite regulation during psychiatric disorders.
METHODS: In 83 depressed, 42 schizophrenic patients and 46 healthy controls plasma ghrelin levels were measured, and the psychometric scores on the Three-Factor Eating Questionnaire (TFEQ) were assessed.
RESULTS: Neither ghrelin levels nor TFEQ scores differed between both patient groups and healthy subjects. However, TFEQ subscale 2 (disinhibition) was predicted by BMI-corrected ghrelin levels, while age, sex, smoking, and medication did not show any influence. DISCUSSION: Ghrelin correlates with factors of eating behavior, specifically with subscale 2 on the TFEQ. Ghrelin might be involved in appetite-regulating pathways during psychiatric disorders. However, its influence is not likely to be displayed as a difference between diagnostic groups. Rather, ghrelin is associated with eating behavior in psychiatric patients meaning susceptibility to eating problems. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552514     DOI: 10.1159/000138915

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  17 in total

Review 1.  Mood disorders: A potential link between ghrelin and leptin on human body?

Authors:  Stalo Zarouna; Greta Wozniak; Anastasia Ioannis Papachristou
Journal:  World J Exp Med       Date:  2015-05-20

2.  Radiometric assay of ghrelin hydrolase activity and 3H-ghrelin distribution into mouse tissues.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2015-10-26       Impact factor: 5.858

3.  Fasting plasma peptide YY concentrations are increased in patients with major depression who associate weight loss.

Authors:  O Giménez-Palop; R Coronas; J Cobo; L Gallart; J D Barbero; I Parra; G Fusté; J Vendrell; M Bueno; J M González-Clemente; A Caixàs
Journal:  J Endocrinol Invest       Date:  2011-12-15       Impact factor: 4.256

4.  Divergent associations between ghrelin and neural responsivity to palatable food in hyperphagic and hypophagic depression.

Authors:  Hilâl Cerit; Kara Christensen; Priyanka Moondra; Anne Klibanski; Jill M Goldstein; Laura M Holsen
Journal:  J Affect Disord       Date:  2018-08-18       Impact factor: 4.839

5.  Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat.

Authors:  Elizabeth A Lawson; Karen K Miller; Justine I Blum; Erinne Meenaghan; Madhusmita Misra; Kamryn T Eddy; David B Herzog; Anne Klibanski
Journal:  Clin Endocrinol (Oxf)       Date:  2012-04       Impact factor: 3.478

6.  Ghrelin's Roles in Stress, Mood, and Anxiety Regulation.

Authors:  Jen-Chieh Chuang; Jeffrey M Zigman
Journal:  Int J Pept       Date:  2010-02-14

Review 7.  The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders.

Authors:  Eva Maria Fritz; Nicolas Singewald; Dimitri De Bundel
Journal:  Front Synaptic Neurosci       Date:  2020-10-27

8.  Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.

Authors:  E Stip; O V Lungu; K Anselmo; G Letourneau; A Mendrek; B Stip; O Lipp; P Lalonde; L A Bentaleb
Journal:  Transl Psychiatry       Date:  2012-06-19       Impact factor: 6.222

Review 9.  Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward.

Authors:  Harriët Schellekens; Timothy G Dinan; John F Cryan
Journal:  Front Neurosci       Date:  2013-08-30       Impact factor: 4.677

10.  Serum ghrelin and leptin levels in patients with depression and the effects of treatment.

Authors:  Saliha Ozsoy; Aslı Besirli; Ummuhan Abdulrezzak; Mustafa Basturk
Journal:  Psychiatry Investig       Date:  2014-04-11       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.